Skip to content

Clinical trials

Completed Phase 2 Extensively Drug-Resistant Tuberculosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Extensively Drug-Resistant Tuberculosis Phase: Phase 2 Status: Completed Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20101
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Global Alliance for TB Drug Development1
Lisichansk Regional Tuberculosis Dispensary1
National Institute of Allergy and Infectious Diseases (NIAID)1
Otsuka Pharmaceutical Development & Commercialization, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Extensively Drug-Resistant Tuberculosis4
Tuberculosis4
Tuberculosis, Multidrug-Resistant4
Tuberculosis, Pulmonary3
Mycobacterium Infections1

Trials

Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.